Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Centogene AG - the Rare Disease Company Germany | 243 | 238 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
STAR - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 406 | 414 |
|
Congenital Adrenal Hyperplasia (CAH) Panel Centogene AG - the Rare Disease Company Germany | 12 | 12 |
|
Invitae Disorders of Sex Development Panel Invitae United States | 88 | 53 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 886 | 547 |
|
Congenital Adrenal Hyperplasia (CAH) Panel PreventionGenetics, part of Exact Sciences United States | 8 | 7 |
|
PreventionGenetics, part of Exact Sciences United States | 128 | 85 |
|
Differences of Sex Development (DSD) Panel PreventionGenetics, part of Exact Sciences United States | 149 | 158 |
|
Differences of Sex Development (DSD) and Infertility Panel PreventionGenetics, part of Exact Sciences United States | 223 | 238 |
|
PreventionGenetics, part of Exact Sciences United States | 128 | 139 |
|
PreventionGenetics, part of Exact Sciences United States | 96 | 105 |
|
Baylor Genetics United States | 842 | 637 |
|
Glucocorticoid Deficiency NGS Panel Fulgent Genetics United States | 19 | 6 |
|
Congenital Adrenal Hyperplasia NGS Panel Fulgent Genetics United States | 32 | 8 |
|
Beacon Expanded Female Carrier Screening Plus Panel Fulgent Genetics United States | 716 | 335 |
|
Beacon Expanded Male Carrier Screening Panel Fulgent Genetics United States | 636 | 298 |
|
Beacon Expanded Male Carrier Screening Plus Panel Fulgent Genetics United States | 661 | 306 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.